Dr. Blanchard is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
830 Harrison Ave
Moakley, 3rd Floor
Boston, MA 02118Phone+1 617-638-6428Fax+1 617-638-5756
Education & Training
- Tufts Medical CenterFellowship, Hematology and Medical Oncology, 1976 - 1980
- Tufts Medical CenterResidency, Internal Medicine, 1974 - 1976
- Weill Cornell MedicineClass of 1974
Certifications & Licensure
- MA State Medical License 1974 - 2021
Awards, Honors, & Recognition
- Top MD Consumers Checkbook
Clinical Trials
- Study of Efficacy and Safety of LEE011 in Men and Postmenopausal Women With Advanced Breast Cancer. Start of enrollment: 2015 Jun 09
Publications & Presentations
PubMed
- 190 citationsTriple-negative breast cancers are increased in black women regardless of age or body mass indexLesley A Stead, Timothy L. Lash, Jerome E Sobieraj, Dorcas D Chi, Jennifer Westrup
Breast Cancer Research. 2009-03-25 - 71 citationsFetal and neonatal von Willebrand factor (vWF) is unusually large and similar to the vWF in patients with thrombotic thrombocytopenic purpura.Mark J. Weinstein, Rita A. Blanchard, Joel L. Moake, Evan Vosburgh And, Kenneth J. Moise
British Journal of Haematology. 1989-05-01 - 396 citationsDes-gamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma.Howard A. Liebman, Barbara C. Furie, Myron J. Tong, Rita A. Blanchard, Kwang-Juei Lo
The New England Journal of Medicine. 1984-05-31
Grant Support
- Randomized Trial Comparing Cisplatin W/Cisplatin PLUS Navelbine In Lung CancerNational Center For Research Resources1995
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: